Clinical Trials Logo

Delirium clinical trials

View clinical trials related to Delirium.

Filter by:

NCT ID: NCT04193280 Recruiting - Clinical trials for Postoperative Delirium

Blood Sugar Level and Postoperative Agitations in Pediatric Surgery

Start date: November 1, 2019
Phase:
Study type: Observational

The aim of this study is to investigate the effect of fasting time and blood glucose levels on postoperative agitations in pediatric patients who will undergo outpatient surgery.

NCT ID: NCT04187807 Recruiting - Delirium in Old Age Clinical Trials

Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department

Start date: October 10, 2019
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of melatonin 5mg in the prevention of Delirium in the older adults in emergency department. Half of the participants will receive melatonin 5mg and the other half will use a starch-based placebo.

NCT ID: NCT04168515 Recruiting - Delirium Clinical Trials

Lived Experiences and Impact of Delirium in Critically Ill Children: a Qualitative Study

Start date: September 10, 2019
Phase:
Study type: Observational

The investigators aim to conduct a qualitative study evaluating the long and short-term recollection and experiences of critically ill children with delirium as well as collect the lived experience of the caregiver and healthcare provider involved in the patient's care. The investigators objective is to determine if there are common themes to these experiences, and if these themes are associated with specific pediatric delirium subtypes (hypoactive, hyperactive, and mixed). The overall goal is to better understand the impact of delirium on patients and their caregivers, and develop strategies to improve education, prevention and management when caring for children with pediatric intensive care unit(PICU)-acquired delirium.

NCT ID: NCT04156464 Recruiting - Alcohol Withdrawal Clinical Trials

Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit

PARTI
Start date: July 6, 2020
Phase: Phase 4
Study type: Interventional

Our aim is to compare outcomes of patients with benzodiazepine-refractory alcohol withdrawal syndrome who are treated with either a phenobarbital-based or a lorazepam based protocol.

NCT ID: NCT04151914 Recruiting - Delirium Clinical Trials

Prevalence of Auditory Dysfunction and ICU-acquired Delirium Following Cardiac Surgery With Cardiopulmonary Bypass: a Prospective Observational Study

AUDICS-ICU
Start date: November 1, 2019
Phase:
Study type: Observational

AUDICS-ICU is a prospective observational aiming to evaluate the prevalence of auditive dysfunction following cardiac surgery. Participants will undergo audiometric testings before and 3 months after cardiac surgery with cardiopulmonary bypass. Furthermore, the study evaluates hearing loss-associated ICU-acquired delirium after cardiac surgery with cardiopulmonary bypass.

NCT ID: NCT04127500 Recruiting - Delirium Clinical Trials

The Mechanism of Dexmedetomidine in Improving Delirium After Cardiac Surgery

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The investigators aim to evaluate the roles of α7nAchR in the mechanisms of dexmedetomidine in improving delirium after cardiac surgery. The results of this study would lay the foundation for revealing the mechanisms of dexmedetomidine improving delirium after cardiac surgery and provide a new idea to the early treatment of delirium.

NCT ID: NCT04122599 Recruiting - Clinical trials for Post Stroke Delirium

Melatonin for Prevention of Post Stroke Delirium

Start date: July 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Post stroke delirium is prevalent in 10-30% of all stroke patients. We aimed to investigate wether Melatonin 2mg may prevent post stroke delirium.

NCT ID: NCT04120272 Recruiting - Spinal Disease Clinical Trials

Discovery for Biomarkers and Risk Factors for Postoperative Delirium in Elderly Patients With Spine Surgery

Start date: October 21, 2019
Phase:
Study type: Observational

Introduction: With the increase of the elderly population, the number of elderly patients undergoing surgery is increasing, and postoperative delirium is 11-51% depending on the type of surgery. In recent cohort studies have shown that delirium might reduce cognitive function and develop dementia. Since delirium is difficult to treat, the key to treatment is prevention, and about 40% is prevented when prophylactic intervention is applied. However, delirium is difficult to diagnose and difficult to predict, therefore, biomarkers are needed to diagnose and prevention. Exosome and brain efficiency test(electroencephalogram, and pulse wave test) have the potential of simple biomarkers that can diagnose postoperative delirium and predict cognitive decline. Purpose: The purpose of this study is to investigate the risk factors affecting delirium in the elderly who have spinal surgery and to search for biomarkers of delirium for early detection and prevention of delirium.

NCT ID: NCT04093219 Recruiting - Clinical trials for Coronary Artery Disease

PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients

PANDORA
Start date: August 11, 2020
Phase: Phase 3
Study type: Interventional

Our objective is to find an effective prophylactic intervention by evaluating IV acetaminophen's impact in reducing the frequency of postoperative delirium, one of the most common and detrimental complications of cardiac surgery in older adults.

NCT ID: NCT04092894 Recruiting - Insomnia Clinical Trials

Suvorexant and Sleep/Delirium in ICU Patients

Start date: February 28, 2020
Phase: Phase 4
Study type: Interventional

Investigators will evaluate the efficacy of postoperative oral suvorexant treatment on nighttime wakefulness after persistent sleep onset (WASO) among adult cardiac surgical patients recovering in the cardiac intensive care unit (ICU). The study include patients ≥ 60 years old undergoing coronary artery bypass graft surgery (CABG), with or without valve surgery (aortic or mitral). Patients will receive either oral suvorexant or placebo for 7 nights starting the night after extubation. The primary hypothesis is that suvorexant compared with placebo decreases WASO, as measured by a specialized electroencephalogram (EEG), the SedLine monitor, during the first night in the cardiac ICU. Investigators will also assess total sleep time (TST), time to sleep onset (TSO), and postoperative delirium and delirium-free days.